Orion Pharma Statistics

Total Valuation

Orion Pharma has a market cap or net worth of BDT 9.97 billion. The enterprise value is 33.56 billion.

Market Cap	9.97B
Enterprise Value	33.56B

Important Dates

The next estimated earnings date is Tuesday, November 26, 2024.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Orion Pharma has 234.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	234.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	25.83%
Owned by Institutions (%)	0.03%
Float	159.16M

Valuation Ratios

The trailing PE ratio is 21.89.

PE Ratio	21.89
Forward PE	n/a
PS Ratio	0.87
PB Ratio	0.46
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.79, with an EV/FCF ratio of -27.48.

EV / Earnings	73.69
EV / Sales	2.92
EV / EBITDA	27.79
EV / EBIT	48.27
EV / FCF	-27.48

Financial Position

The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.96.

Current Ratio	1.86
Quick Ratio	1.46
Debt / Equity	0.96
Debt / EBITDA	18.64
Debt / FCF	-18.30
Interest Coverage	4.60

Financial Efficiency

Return on equity (ROE) is 2.01% and return on invested capital (ROIC) is 0.95%.

Return on Equity (ROE)	2.01%
Return on Assets (ROA)	0.81%
Return on Capital (ROIC)	0.95%
Revenue Per Employee	4.23M
Profits Per Employee	167,695
Employee Count	2,716
Asset Turnover	0.22
Inventory Turnover	4.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.48%
50-Day Moving Average	40.29
200-Day Moving Average	63.31
Relative Strength Index (RSI)	56.07
Average Volume (20 Days)	2,099,181

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Pharma had revenue of BDT 11.50 billion and earned 455.46 million in profits. Earnings per share was 1.95.

Revenue	11.50B
Gross Profit	2.17B
Operating Income	686.03M
Pretax Income	563.71M
Net Income	455.46M
EBITDA	1.18B
EBIT	686.03M
Earnings Per Share (EPS)	1.95

Full Income Statement

Balance Sheet

The company has 250.87 million in cash and 22.34 billion in debt, giving a net cash position of -22.07 billion or -94.31 per share.

Cash & Cash Equivalents	250.87M
Total Debt	22.34B
Net Cash	-22.07B
Net Cash Per Share	-94.31
Equity (Book Value)	23.29B
Book Value Per Share	93.01
Working Capital	7.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.62 billion and capital expenditures -2.84 billion, giving a free cash flow of -1.22 billion.

Operating Cash Flow	1.62B
Capital Expenditures	-2.84B
Free Cash Flow	-1.22B
FCF Per Share	-5.22

Full Cash Flow Statement

Margins

Gross margin is 18.85%, with operating and profit margins of 5.97% and 3.96%.

Gross Margin	18.85%
Operating Margin	5.97%
Pretax Margin	4.90%
Profit Margin	3.96%
EBITDA Margin	10.26%
EBIT Margin	5.97%
FCF Margin	-10.62%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.35%.

Dividend Per Share	1.00
Dividend Yield	2.35%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	23.81%
Buyback Yield	n/a
Shareholder Yield	2.35%
Earnings Yield	4.57%
FCF Yield	-12.25%

Dividend Details

Stock Splits

The last stock split was on May 27, 2013. It was a forward split with a ratio of 1.2.

Last Split Date	May 27, 2013
Split Type	Forward
Split Ratio	1.2

Scores

Orion Pharma has an Altman Z-Score of 1.02. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.02
Piotroski F-Score	n/a